Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Neoplasms 1 Uveal Melanoma 1 Thyroid Neoplasms 1 Sarcoma, Ewing 1 Neoplasm Metastasis 1 Melanoma 1 Iris Neoplasms 1 Choroid Neoplasms 1 Breast Neoplasms 1

Interventions

vandetanib 1 pembrolizumab 1 lenvatinib 1 fosbretabulin 1 fludarabine 1 combretastatin 1 aldesleukin 1 Water 1 Thyroxine 1 Thyrotropin-Releasing Hormone 1 Tea 1 Paclitaxel 1 Milk 1 Iodine-124 1 Iodine-123 1 Fluorodeoxyglucose F18 1 Drug Therapy 1 Docetaxel 1 DNA 1 Cyclophosphamide 1 Coffee 1 Carboplatin 1 Biopsy, Fine-Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Thyroid Neoplasms × Biopsy, Fine-Needle × Clear all

NCT00954837 2013-05-27

CYT2THYR

Assistance Publique - Hôpitaux de Paris

Phase NA Withdrawn

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡